1.	Project Details

   Whether it is a violation case and application is being submitted under Notification No. S.O.804(E) dated 14.03.2017 ? : No

1.	Project Details

   i. Proposal No. : IA/UK/IND2/61486/2017    ii. MoEFCC File No. : IA-J-11011/4/2017-IA-II(I)    iii.Short narrative of the project: Ish Medicos Pvt Ltd    iv. Project Sector : Industrial Projects-2    v. Company/Proponent : ISH MEDICOS

vi.Details of State of the project

Details of State of the project
S.no.	State Name	District Name	Tehsil Name
1.	Uttarakhand	Dehradun	Vikasnagar

   vii.Date of TOR Granted 29 Apr 2017 viii.TOR letter issued by Ministry: Annexure-TOR letter ix.Date of Submission for EC: 04 Jul 2017 x.Project Type: New

2.	Uploaded Documents of EIA/EMP,Risk Assessment,Public Hearing etc.

i.EIA/EMP: Annexure-EIA/EMP ii.Risk Assessment: Annexure-Risk Assessment iii.Public Hearing: Annexure-Public Hearing    iv. Date of Public Hearing: 30 Jun 2017   v. Uploaded Additional Report/Study/Document as desired by Ministry/EAC: Annexure-Additional Report/Study/Document   vi. Uploaded Cover Letter: Annexure-Cover Letter   vii.Remarks: Public hearing exempted by EIC committee.

3.	Additional Detail Sought

Additional Detail Sought
Sno.	ADS Letter	Remarks	Date of ADS
1.	NA	The EAC, after detailed deliberations on the proposal, observed that the Principal EIA Notification, 2006 and the subsequent amendments therein, do not provide for the requirement of prior EC for drug formulation units. However, at the same time, as per the Ministry’s Notification dated 4th July, 2005, the proposals covered under the orange category are to be dealt with as industries requiring EC as per the Environment Impact Assessment Notification, 1994 issued vide No.S.O.60€ dated the 27th January, 1994. As such, there seems to be a contradiction and needs to be resolved by the Ministry. The Committee further desired that the matter may be examined in the perspective of present categorization of industries vis-à-vis the extant provisions of the EIA Notification, 2006 and the amendments	04 Sep 2017
2.	ADS Letter	Dear Sir, We would like to bring to your kind notice that application for obtaining the environment clearance for the above mention project was submitted to MoEF, New Delhi in December 2016. The first technical presentation (for TOR approval) was held before EAC meeting during Janaury 23, 2017 to January 25, 2017 and subsequently, TOR approval was granted on April 29, 2017. The aforesaid proposal was considered by the expert appraisal committee (Industry -2) EAC in its Meeting held from 28/08/2017 to 29/08/2017. The EAC, after detailed deliberations on the proposal, observed that the Principal EIA Notification, 2006 and the subsequent amendments therein, do not provide for the requirement of prior EC for drug formulation units. However, at the same time, as per the Ministry’s Notification dated 4th July, 2005, the proposals covered under the orange category are to be dealt with as industries requiring EC as per the Environment Impact Assessment Notification, 1994	01 Nov 2017

4.	Accredited Consultant Details

   i. Accreditation status : Yes    ii. Accreditation No. : MIE(I)CA    iii. Name of Consultant: Ravi shankar juyal   iv. Address : 338/II, Vasant Vihar, Phase-2,Dehradun-248006   v. Mobile No.: 9897622722   vi. Landline No.: 01352721446   vii. Email Id: ish@ishpharma.com

5.	Undertaking

I hereby give undertaking that the data and information given in the application and enclosures are true to be best of my knowledge and belief and I am aware that if any part of the data and information found to be false or misleading at at any stage, the project will be rejected and clearance given, if any to the project will be revoked at our risk and cost.

   i. Name of Applicant : Ish    ii. Designation : Director    iii. Name of Company(Applicant Name should not be given here) : ISH MEDICOS    iv. Address : 15, Kanawali road, Dehradun v. Uploaded copy of documents in support of the competence/authority of the person making this application to make application on behalf of the User Agency: Annexure-Uploaded copy of documents in support of the competence/authority of the person making this application to make application on behalf of the User Agency